Abstract
We present a mixed experimental/theoretical determination of the bond strengths and redox potentials that define the ground state thermodynamics for C-H bond activation in cytochrome P450 catalysis. Using redox titrations with [Ir(IV)Cl6]2− we have determined the compound II/ferric (or Fe(IV)OH/Fe(III)OH2) couple and its associated D(O-H)Ferric bond strength in CYP158. Knowledge of this potential as well as the compound II/ferric (or Fe(IV)O/Fe(III)OH) reduction potential in horseradish peroxidase and the two-electron compound I/ferric (or Fe(IV)O(Por•)/Fe(III)OH2(Por)) reduction potential in aromatic peroxidase has allowed us to gauge the accuracy of theoretically determined bond strengths. Using the restricted open shell (ROS) method as proposed by Wright and coworkers, we have obtained O-H bond strengths and associated redox potentials for charge-neutral H-atom-reductions of these iron(IV)-hydroxo and −oxo porphyrin species that are within 1 kcal/mol of experimentally determined values, suggesting that the ROS method may provide accurate values for the P450-II O-H bond strength and P450-I reduction potential. The efforts detailed here indicate the ground state thermodynamics of C-H bond activation in P450 are best described as follows: E0’Comp-I = 1.22 V (at pH 7, vs. NHE) with D(O-H)Comp-II = 95 kcal/mol, and E0’Comp-II = 0.99 V (at pH 7, vs. NHE) with D(O-H)Ferric = 90 kcal/mol.
Graphical Abstract

INTRODUCTION
The controlled activation of inert C-H bonds remains one of the grand challenges of synthetic chemistry.1 In an effort to further our understanding of this important class of transformations, we have sought to examine fundamental aspects of C-H bond activation in cytochrome P450 (P450) catalysis.2−5 P450s are a class of thiolate-ligated heme proteins that excel at C-H bond activation.6 These enzymes utilize molecular oxygen and the formal equivalents of dihydrogen (2H+ + 2e−) to catalyze the oxidation of a broad range of biomolecules.6−9 The principal intermediates in these reactions are a pair of high-valent iron-oxo and ironhydroxo species called compounds I and II.4,5 Although recent electronic and structural characterizations of these reactive intermediates have provided significant insight into metal-oxo mediated C-H bond activation, important questions remain.
There is currently a debate in the field about the importance of ground state thermodynamics in metal-oxo driven C-H bond activation. The debate centers on whether ground state thermodynamics play the dominant role in determining reactivity or whether some other property of the system (e.g. oxyl-radical character, metal-oxo basicity, metal-oxo spin state, width of the activation barrier, or multi-state reactivity) can provide an intrinsic lowering of the activation barrier.10–19 The examination of this fundamental issue has been hindered not only by the difficulty of quantifying these properties for highly-reactive high-valent species but also by the lack of a series of isoelectronic and isostructural compounds over which these properties can be varied.
Ground state thermodynamics, in the form of Linear Free Energy Relationships (LFER), have often been used to explain metal-oxo mediated C-H bond activation.20–22 From this viewpoint, P450 reactivity can be understood in terms of the strength of the O-H bond formed during H-atom abstraction.5 Figure 1 shows D(O-H)Comp-II, the homolytic bond-dissociation free energy of the iron(IV)hydroxide center in P450 compound II (P450-II). Within the LFER framework, this is the key parameter that determines the reactivity of compound I towards C-H bonds. Fig. 1 also shows D(O-H)Ferric of the ferric water-bound heme. P450s have been found to perform desaturation and carbon-carbon bond cleaving reactions, in which P450-II oxidizes the substrate a second time.23–29 These oxidations involve either direct H-atom abstraction or a proton-coupled oxidation of the substrate radical to generate the ferric water-bound form of the enzyme. In a similar fashion, one expects the non-rebound reactivity of P450-II towards hydrocarbons to be dictated by D(O-H)Ferric. In principle, both of these bond strengths could be determined from the reduction potentials of P450-I (E0’Comp-I) and P450-II (E0’Comp-II), using equations 1 and 2 shown in the methods section. However, to date, neither of these quantities has been reported.
Figure 1.

Bonds strengths that define the ground state thermodynamics of P450 catalysis. D(O-H)Comp-II is the strength of the O-H bond in P450 compound II. D(O-H)Ferric is the O-H bond strength in the ferric water-bound form of the enzyme.
Herein we present a mixed experimental/theoretical determination of the bond strengths and redox potentials that define the ground state thermodynamics for C-H bond activation in P450 catalysis. Although the highly reactive nature of P450-I presents a significant obstacle to the experimental determination of the P450-I/P450-II redox couple, we have found that the P450-II/ferric couple is amenable to redox titrations with [Ir(IV)Cl6]2−. Knowledge of this potential as well as the compound II/ferric (or Fe(IV)O/Fe(III)OH) reduction potential in horseradish peroxidase30 and the two-electron compound I/ferric (or Fe(IV)O(Por•)/Fe(III)OH2(Por)) reduction potential in aromatic peroxidase31 has allowed us to gauge the accuracy of theoretically determined bond strengths. Using the restricted open shell (ROS) method as proposed by Wright and coworkers32, we have obtained O-H bond strengths associated with the charge-neutral H-atom-reductions of iron(IV)-oxo and -hydroxo porphyrin species that are within 1 kcal/mol of the values obtained from the experimentally determined potentials, suggesting that the ROS method may provide accurate values for D(O-H)Comp-II and the P450-I reduction potential. We detail these results below.
RESULTS
Experimental Determination of the P450 Compound II/Ferric potential
Using methods similar to those employed by Hayashi and Yamazaki in their experiments on horseradish peroxidase30, the reduction potential of P450-II was determined by monitoring the stopped-flow reaction of [Ir(IV)Cl6]2− with ferric CYP158.33,34 This isoform of P450 was chosen because CYP158-II can be generated in very high yield (~100%, Figure S2) and the intermediate is relatively stable over a wide pH range.5 Three phases of the reaction of ferric CYP158 with [Ir(IV)Cl6]2− can be seen in Figure 2, which shows the absorbance at 430 nm as a function of time. Initially, there is rapid formation of compound II as [Ir(IV)Cl6]2− oxidizes ferric enzyme. This rapid formation is followed by a period of pseudo-equilibrium where there is very little change in the concentrations of the reactive species. Finally there is a region of decay as both the [Ir(IV)Cl6]2− and CYP158-II concentrations decrease. During this final phase, CYP158-II decays to ferric enzyme, which can be reoxidized, but as the reaction proceeds and [Ir(IV)Cl6]2− is consumed there is less driving force for compound II formation. Additionally, there is a small, but not insignificant, (~6% on average) decay of [Ir(IV)Cl6]2− due to hydrolysis.35
Figure 2.

Time trace at 430 nm of reaction between CYP158 and [Ir(IV)Cl6]2− at pH 8.3. The reaction can be divided into three distinct phases. It begins with Phase I, dominated by the forward reaction (i.e. formation of P450-II). This is followed by a brief period of pseudo-equilibrium, denoted by Phase II. This is the phase where the potentials are determined from the concentration of each species. This is followed by Phase III, which is dominated by decay of P450-II back to ferric enzyme.
The reduction potential of CYP158-II was obtained from the Nernst equation using concentrations of reactive species in the pseudo-equilibrium phase (Phase II, Figure 2). For each stopped-flow reaction, several time points in this region (generally four but not less than three) were selected (see Supporting Information for details). For each of these points, the experimental UV/visible spectrum (300–700 nm) was simulated using the known spectra of ferric CYP158, CYP158-II, and [Ir(IV)Cl6]2− to obtain the concentrations of these species (Figure 3). Given that the extinction coefficient of [Ir(III)Cl6]3− is significantly less (see methods) than those of the other species in the reaction, it was not possible to determine the concentration of the Ir(III) complex directly from simulations of the UV/visible spectra. For our calculations of the reduction potential, the concentration of [Ir(III)Cl6]3− was set equal to the amount [Ir(IV)Cl6]2− consumed, minus losses of [Ir(IV)Cl6]2− due to hydrolysis. The losses due to hydrolysis were determined from separate stopped-flow reactions in which [Ir(IV)Cl6]2− was mixed with the appropriate buffer. Potentials obtained from multiple time points in the pseudo-equilibrium region were averaged to obtain a potential for each stopped-flow reaction. The results from three different stopped-flow experiments were then averaged to obtain the potentials reported here. The [Ir(IV)Cl6]2−/[Ir(III)Cl6]3− potential was measured to be 900 mV vs. NHE, identical to the previously reported value.36
Figure 3.

Experimental and simulated spectra from the pseudo-equilibrium region (490 ms, Fig. 2) using pure spectra of ferric CYP158, CYP158-II, and [Ir(IV)Cl6]2−. The residual shows the difference between the experimental and simulated data.
The values of E0’Comp-II determined in the pH range 8.0 to 9.5 are listed in Table 1. Plotting the values against pH reveals a linear relationship with a slope of 58 mV (Figure 4). This value, which is very close to the expected value of 59 mV/pH, suggests that the concentrations obtained in the pseudo-equilibrium region are indeed representative of equilibrium concentrations.
Table 1.
E0’Comp-II vs. NHE as a function of pH. The average uncertainty is ±5 mV.
| pH | 8.0 | 8.3 | 8.7 | 9.0 | 9.3 | 9.5 |
| E0’Comp-II (mV) | 935 | 909 | 896 | 875 | 856 | 846 |
Figure 4.

E0’Comp-II versus pH.
As noted above, due to its relatively low extinction coefficient, the concentration of [Ir(III)Cl6]3− at equilibrium cannot be determined directly from UV/visible spectroscopic measurements. As a result, previous investigations of the reduction potentials of HRP compounds I and II made the assumption that one equivalent of [Ir(III)Cl6]3− was generated for every equivalent of compound I and/or compound II obtained.30,37 George, however, noted in his studies with metmyoglobin that ~1.5 equivalents of [Ir(IV)Cl6]2− were consumed for each equivalent of ferryl myoglobin generated. The consumption of extra oxidizing equivalents was attributed to “reduction of the potassium chloriridate by other reducing groups, either on the protein or present as impurities in the preparation”.38
In line with George’s observation, we have found that the ratio of [[Ir(III)Cl6]3−]/[CYP158-II] in the pseudo-equilibrium region is ~ 2.2, indicating that ~ twice as much [Ir(IV)Cl6]2− had been consumed as CYP158-II generated. It is known that CYP158 possess several tyrosines in close proximity to the active site.33,34 We have shown that two of these (Tyr-352, Tyr-318) are oxidized during the reaction of meta-chloroperbenzoic acid with ferric CYP158.5 The most readily oxidized is Tyr-352, a solvent-exposed residue, which is adjacent to the Cys-353 thiolate ligand.5 Substituting a Phe at position 352 drops the [[Ir(III)Cl6]3−]/[CYP158-II] ratio to ~1.4, while the double mutation (Y352F, Y318F) drops ratio to ~1. The reduction potentials and [[Ir(III)Cl6]3−]/[CYP158-II] ratios for the wild type and mutant enzymes at pH 8.3 are listed in Table 2. These potentials of the WT and mutant enzymes span a range of 30 mV, which is equivalent to <1 kcal/mol in bond strength.
Table 2.
E0’Comp-II (at pH 8.3 vs. NHE) and [[Ir(III)Cl6]3−]/[P450-II] ratio for the wild type, single mutant, and double mutant CYP158A2. The average uncertainty is ±5 mV.
| WT | Y352F | Y352F, Y318F | |
|---|---|---|---|
| E0’Comp-II (mV) | 909 | 892 | 879 |
| [[Ir(III)Cl6]−3]/[P450-II] | 2.1–2.3 | 1.3–1.5 | 0.9–1.0 |
In concluding this section, we note that we have considered the loss of [Ir(IV)Cl6]2− oxidizing equivalents (either due to hydrolysis and/or to protein side-chain oxidation) in effort to obtain the most accurate potentials possible. However, we have found that, in practice, these losses can be ignored without any significant impact on the measured potentials or bond strengths. Excluding losses due to hydrolysis and side chain oxidation from our analyses (which is equivalent to assuming that [[Ir(III)Cl6]3−]/[CYP158-II] =1 for the wild type enzyme) changes the potentials obtained by an average of 20 mV.
Experimental and Theoretical Bond Strengths
A goal of our investigations is to map out the ground state thermodynamics of C-H bond activation in cytochrome P450. The redox titrations outlined above have provided potentials, which can be used to determine the D(O-H)Ferric of the ferric water bound enzyme. Using the values listed in Table 1 and Table 2, one obtains 90 ± 1 kcal/mol for this bond.
[Ir(IV)Cl6]2− cannot be used to access the E0’Comp-I couple, as [Ir(IV)Cl6]2− does not have enough driving force to oxidize P450-II to P450-I. To provide insight into the strength of the O-H bond in compound II, we sought to examine the ability of density functional calculations to predict O-H bond strengths for iron-porphyrin complexes. It has been shown that a semi-empirical application of the restricted open-shell (ROS) DFT method can yield O-H bond strengths with an average deviation of ~1 kcal/mol from experimentally determined values.32 However, while the semi-empirical ROS method has been successfully applied to a large number of molecular systems, its utility for transition metal complexes has not been tested.
Using the ROS method (see methods section) as described by Wright and coworkers32, we calculated O-H bond strengths associated with charge neutral H-atom reductions for three experimentally determined iron-porphyrin redox couples: the Fe(IV)OH/Fe(III)OH2 couple of P450 reported here, the Fe(IV)O/Fe(III)OH couple of HRP reported by Hayashi and Yamazaki,30 and the Fe(IV)O(Por•)/Fe(III)OH2(Por) couple for the thiolate-ligated compound I intermediate of aromatic peroxidase (APO, vida infra) reported by Groves and coworkers.31
The ROS calculations were performed on simple iron-porphine models possessing the appropriate proximal ligand (methyl thiolate or imidazole). Calculated BDFEs (and their associated redox potentials) were found to be within 1 kcal/mol of the values determined by experiment.39 Bond strengths obtained from theory (experiment) for the ferric hydroxide form of HRP are 85 (85) kcal/mol,30 while the values obtained for the ferric water bound form of P450 are D(O-H)Ferric = 89 (90) kcal/mol. Additionally, the two-electron potential for reduction of a thiolate ligated compound I was calculated to be E0’Comp-I/Ferric = 1.09 V (pH 7), which compares well to the value of 1.12 V (pH 7) obtained from experiments on APO-I.31
The ROS method has provided results in good agreement with three different experimentally determined redox couples. Importantly, two of these couples involve the thiolate-ligated compound I and compound II species that define D(O-H)Comp-II. This suggests that the method can provide an accurate value for the O-H bond strength for P450-II as well as the associated P450-I reduction potential. Application of the ROS method to the P450-I/P450-II couple provides a D(O-H)Comp-II bond strength of 95 kcal/mol and a proton coupled reduction potential of E0’Comp-I = 1.22 V at pH 7.0.
DISCUSSION AND CONCLUSION
P450s are best known for their role in hydrocarbon oxygenations, but the enzymes can also perform desaturation and carbon-carbon bond cleaving reactions. P450s have been shown to play a role in the generation of vinyl carbamate from ethyl carbamate (a known carcinogenic pathway), the desaturation of testosterone to give 17β-hydroxy-4,6-androstadiene-3-one, the dehydrogenation of acetaminophen to iminoquinone (which is responsible for hepatic necrosis in high doses), and the production of Cn-1 alkenes from Cn fatty acids.23,27–29,40 All of these transformations involve an initial H-atom abstraction by compound I to form an iron(IV)hydroxide species (i.e. compound II) and a substrate radical. However, instead of collapsing to give the hydroxylated product, P450-II oxidizes the substrate a second time. This oxidation can involve either direct H-atom abstraction or a proton-coupled oxidation of the substrate radical. The P450-II reduction potential and D(O-H)Ferric reported here (0.909 mV at pH 8.3, and 90 kcal/mol, respectively) provide the driving force in either case.
Reports of aqueous potentials associated with the charge neutral (i.e. H-atom) reduction of iron(IV)oxo and iron(IV)hydroxide heme-systems are rare. The enzyme horseradish peroxidase is the only system for which we have found direct measurements in the literature that can be associated with an O-H bond strength.30 Hayashi and Yamazaki, using techniques similar to those employed here (i.e. spectrophotometric titrations with ferricyanide), measured the iron(IV)oxo/iron(III)hydroxide couple in HRP. They obtained a value of 0.523 V at pH 11.2, corresponding to an O-H bond strength of 85 kcal/mol for the ferric hydroxide form of the enzyme.13
The direct measurement of O-H bond strengths in a thiolate-ligated heme system has not been previously reported, but Groves and coworkers have used reaction kinetics to estimate the O-H bond strengths of the iron(IV)hydroxide and ferric water-bound forms of APO.41 APO is a thiolate-ligated heme enzyme that can utilize hydrogen peroxide to efficiently oxidize a number of unactivated hydrocarbons. Based on the rates of the oxidation of p-toluic acid and p-ethylbenzoic acid by APO compound I, a BDE of ~103 kcal/mol (BDFE of ~105 kcal/mol) was estimated for the O-H bond of APO-II (a value that is 10 kcal/mol greater than the value predicted here for P450-II).39,41 Additional kinetic measurements, to determine the equilibrium constants for the reaction of APO with hypohalous acids, provided the two-electron potential for APO-I reduction, E0’Comp-I/Ferric =1.12 V at pH 7.31 From the one- and two-electron potentials of APO-I, one can obtain an APO-II reduction potential of 0.60 V (pH 7), corresponding to an O-H bond strength of 81 kcal/mol for the ferric water-bound form of the enzyme (which is 9 kcal/mol less than the value obtained for ferric P450.)
Among heme proteins, only those with axial thiolate ligation are known to activate C-H bonds. Evidence suggests that the thiolate ligand may play a dual role in this process, protecting the enzyme from oxidative damage, while increasing the reactivity of the ferryl oxygen towards hydrocarbons.5,42,43 How the thiolate increases the reactivity of compound I remains a topic of active research, and there are differing viewpoints regarding the factors that control/promote C-H bond activation by metal-oxo complexes.2,3 Debate in the field centers upon on whether ground state thermodynamics play the dominant role in determining reactivity or whether some other property (e.g. oxyl-radical character, metal-oxo basicity, metal-oxo spin state, the width of the activation barrier, or multi-state reactivity) can provide an intrinsic lowering of the activation barrier.10–19
Given that P450 and APO have similar coordination environments and reactivity (i.e. both possess thiolate-ligated hemes that efficiently oxygenate unactivated hydrocarbons), the bond strengths outlined above for these systems are surprising. One might expect these enzymes to possess similar thermodynamics for C-H bond activation. It must be remembered, however, that the only potentials known from direct measurements on these systems are the two-electron potential of APO-I and the one-electron potential of P450-II. Using the values reported for these potentials (E0’Comp-I/Ferric = 1.12 V, E0’Comp-II = 0.99 V), one can estimate a P450-II (or APO-II) O-H bond strength of 96 kcal/mol, a value that is within 1 kcal/mol of the value (95 kcal/mol) predicted by ROS calculations on a simple thiolate-ligated iron-porphine model system. These same computational methods yield a two-electron reduction potential of E0’Comp-I/Ferric =1.09 V for a thiolate-ligated compound I at pH 7, a value that differs by only 0.03 V (<1 kcal/mol) from the experimentally determined two-electron potential for APO-I reduction.31
The 95 kcal/mol BDFE predicted for D(O-H)Comp-II in these thiolate ligated systems is interesting given the highly reactive nature of thiolate ligated compound I species. In the synthetic literature, it is common practice to estimate (or bracket) metal-hydroxide bond strengths based on the strength of the C-H bonds that the parent oxo-complex can oxidize, and second order rate constants for the reaction of synthetic metal oxo complexes with organic substrates have been found to be severely attenuated when BDEC-H ≥ BDEO-H.16,44–47 However, direct comparisons of solution second order rate constants for molecular and enzymatic systems are problematic. Reactions depend critically upon collisions between reactive species, and enzymatic systems bind their substrates in close proximity to the metal-oxo moiety, increasing residence time near the transition state.
Experiments with CYP119 have shown that P450-I oxidizes the ω-1 position of C6-C12 fatty acids (BDFE~101 kcal/mol) at 104-107 M−1s−1, while the oxidation of bound substrate can exceed 1400 s−1 at 4°C.4 The rapid rate of bound substrate oxidation would appear to be at odds with theoretical investigations that have typically predicted activation barriers on the order of 18–20 kcal/mol for H-atom abstraction by P450-I.48–51 However it has been argued that zero point effects, dispersion interactions, and proton tunneling can reduce calculated barriers to values that are consistent with experimentally determined rate constants.48–53
Recently there has been renewed interest in the role that quantum mechanical tunneling plays in metal-oxo mediated C-H bond activation.14,15,54–56 It has been suggested that the ligand trans to the oxo ligand plays an important role in shaping the potential energy surface to promote H-atom transfer. In theoretical investigations of the oxidation of 9,10-dihydroanthracene (DHA) and cyclohexadiene (CHD) by series of tetramethylcyclam (TMC) supported iron(IV)oxo complexes, it was found that donating axial ligands lead to a reduction in barrier width, increasing proton tunneling efficiency.15 For the oxidation of CHD by series of (TMC)FeIVO complexes with different axial ligands, a thiolate ligated species was found to have the narrowest barrier for H-atom transfer.56 Based on their work, Klein and coworkers argued that the thiolate ligand has a privileged role in these oxidations, increasing the reactivity by shaping the potential energy surface and inducing significant tunneling.15
Mayer has convincingly argued that thermodynamics (and not oxyl-radical character, oxo basicity, spin state, or quantum mechanical tunneling) must be the key factor that determines the reactivity for single step H-atom transfers.13 This is because the ratio of the forward and reverse rate constants is dictated by the equilibrium constant. For an endergonic reaction, a large rate constant in the forward direction means an even larger rate constant in the reverse direction.
Consider for example the oxidation of dodecanoic acid at the ω-1 position by CYP119-I.4 The results presented here indicate that the H-atom abstraction step is ~6 kcal/mol uphill. Given these thermodynamics, if P450-I abstracts an H-atom from the substrate with a rate constant of 2000 s−1, the rate constant for the return of the H-atom to the substrate radical must be ~108 s−1. Thus, it can be inferred that P450 function hinges upon a rapid rebound step, in which the newly formed hydroxide ligand and the substrate radical combine to yield hydroxylated product.
Using radical clocks, the rebound step in P450s has been estimated to have a rate constant on the order of 1010 to 1011 s−1.57 A rate constant of this magnitude precludes back transfer of the H-atom to substrate, based on the rate constants and thermodynamics outlined above. Importantly, a rapid rebound step provides a mechanism by which an increase in the forward rate constant for H-atom abstraction creates a more reactive hydroxylating intermediate irrespective of the equilibrium constant for H-atom transfer (Figure 5). The activation barrier may still be a function of ground state thermodynamics, but, given the rapid rate of rebound, it is conceivable that some other property of the system (oxyl-radical character, metal-oxo basicity, quantum mechanical tunneling, protein dynamics, etc.) could provide an intrinsic lowering of the barrier, increasing the rate constant for H-atom abstraction without the penalty of an increased back transfer rate.
Figure 5.

General illustration depicting how a rapid rebound step provides a mechanism through which an increase in the forward rate constant for H-atom abstraction creates a more reactive hydroxylating intermediate irrespective of the equilibrium constant for H-atom transfer. kf is the forward rate constant for H-atom transfer. kr is the reverse rate constant for H-atom transfer. kR is the rate constant for rebound.
Recently we reported an isoelectronic and isostructural perturbation to P450-I that may provide insight into the ability of these factors to augment the contributions of thermodynamics to reactivity.3 Through the use of a cysteine auxotrophic cell line, we obtained a selenocysteine-ligated variant of CYP119. Although ROS calculations indicate that D(O-H)Comp-II is identical for the thiolate- and selenolate-ligated systems, experiments have revealed that SeCYP119-I is significantly more reactive towards C-H bonds. This elevated reactivity has been attributed to increased electron donation from the selenolate ligand. Just how this increased electron donation manifests itself in terms of a more reactive P450-I remains to be determined.
Experimental and Computational Methods
Materials:
Potassium hexachloroiridate(IV) was obtained from Sigma Aldrich. CYP158 was over-expressed in BL21 cells and purified as reported previously.5 Only protein fractions with an Rz ≥ 2 were used for experiments.
Stopped-Flow Spectrophotometry:
Spectral changes were monitored using an SFM-400 stopped flow rapid scan spectrometer (Bio-Logic SA, Claix, France). An L7893 light source (Hamamatasu, Tokyo, Japan) and a TIDAS photodiode was used to collect absorption data. All experiments were performed at 7°C.
Cyp158A2 Reaction:
20 uM CYP158A2 in 25mM tris-HCl buffer (pH 8, 8.3, 8.7, 9.0, 9.3, and 9.5) was mixed with 100 uM (or 200 uM) K2IrCl6, to yield final concentrations of 10uM and 50uM (or 100 uM), respectively. A fresh stock solution of 2.5 mM K2IrCl6 in nanopure water was made before each set of experiments and diluted as necessary. The pH of the final reaction mixture was measured and found to be the same as the pH of the protein solution before mixing.
Extinction Coefficients Used to Determine Concentrations:
The following extinction coefficients were used: ferric CYP158 (ε416 nm = 100,000 M−1cm−1), CYP158-II (ε426 nm = 69,000 M−1cm−1), [Ir(IV)Cl6]2− (ε491 nm = 3,064 M−1cm−1), [Ir(III)Cl6]3−(ε491nm~ 100 M−1cm−1). Further details on these values, how they were used, and how the concentration of [Ir(III)Cl6]3− was determined can be found in Supporting Information.
Calculations:
O-H bond strengths were calculated using the ROS method as described by Wright and coworkers.32 Calculations were performed at the MLM2, which involves geometry optimizations and frequency analyses at the UB3LYP/6–31G(d) level, followed by a single point calculation at the ROB3LYP/6–311+G(2d,2p) level. Zero point energies and enthalpy corrections were scaled by 0.9806 and 0.9989, respectively. A key feature of the technique as described by Wright and coworkers is that the energy of atomic hydrogen is set equal to its exact value −1.0 Ry. Calculations were performed on simple iron-porphine models with the appropriate axial ligands. All calculations were performed with Gaussian 09.58
Relationship between Redox Potential and Bond Strength:
For an aqueous proton-coupled reduction, the relationship between the potential (vs. NHE) and the bond strength (in kcal/mol) is given by:
| Eq. 1 |
For the two-electron two-proton coupled reduction of compound I to ferric enzyme, the relationship is given by:
| Eq. 2 |
Supplementary Material
ACKNOWLEDGMENT
The authors thank Julio C. Calixto for insights gained during his efforts to measure the P450-II reduction potential.
Funding Sources
This work was supported by the NIH (R01-GM101390).
ABBREVIATIONS
- P450
cytochrome P450
- HRP
horseradish peroxidase
Footnotes
Supporting Information. Determination of pseudo-equilibrium concentrations and the [[Ir(III)Cl6]3−]/[CYP158-II] ratio for a representative stopped-flow reaction. Mössbauer data for a P450-II sample prepared by the reaction of ferric enzyme with [Ir(IV)Cl6]2−. Electrochemical methods and data for the [Ir(IV)Cl6]2−/[Ir(III)Cl6]3− couple.
REFERENCES
- 1.Hartwig JF; Larsen MA Undirected, Homogeneous C–H Bond Functionalization: Challenges and Opportunities. ACS Cent. Sci 2016, 2, 281. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Krest CM; Silakov A; Rittle J; Yosca TH; Onderko EL; Calixto JC; Green MT Significantly shorter Fe-S bond in cytochrome P450-I is consistent with greater reactivity relative to chloroperoxidase. Nat. Chem 2015, 7, 696. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Onderko EL; Silakov A; Yosca TH; Green MT Characterization of a selenocysteine-ligated P450 compound I reveals direct link between electron donation and reactivity. Nat. Chem 2017, 9, 623. [DOI] [PubMed] [Google Scholar]
- 4.Rittle J; Green MT Cytochrome P450 Compound I: Capture, Characterization, and C-H Bond Activation Kinetics. Science 2010, 330, 933. [DOI] [PubMed] [Google Scholar]
- 5.Yosca TH; Rittle J; Krest CM; Onderko EL; Silakov A; Calixto JC; Behan RK; Green MT Iron(IV)hydroxide pKa and the role of thiolate ligation in C-H bond activation by cytochrome P450; and the Role of Thiolate Ligation in C–H Bond Activation by Cytochrome P450. Science 2013, 342, 825. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Oritz de Montellano PR Cytochrome p450: Structure, Mechanism, and Biochemistry, Third Edition. Kluwer academic/plenum; publishers, New York: 2005. [Google Scholar]
- 7.Ortiz de Montellano PR Hydrocarbon Hydroxylation by Cytochrome P450 Enzymes. Chem. Rev 2010, 110, 932. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Denisov IG; Makris TM; Sligar SG; Schlichting I Structure and Chemistry of Cytochrome P450. Chem. Rev 2005, 105, 2253. [DOI] [PubMed] [Google Scholar]
- 9.Krest CM; Onderko EL; Yosca TH; Calixto JC; Karp RF; Livada J; Rittle J; Green MT Reactive Intermediates in Cytochrome P450 Catalysis. J. Biol. Chem 2013, 288, 17074. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Mayer JM Understanding Hydrogen Atom Transfer: From Bond Strengths to Marcus Theory. Acc. Chem. Res 2011, 44, 36. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Dietl N; Schlangen M; Schwarz H Thermal Hydrogen-Atom Transfer from Methane: The Role of Radicals and Spin States in Oxo-Cluster Chemistry. Angew. Chem 2012, 51, 5544. [DOI] [PubMed] [Google Scholar]
- 12.Lai W; Li C; Chen H; Shaik S Hydrogen-Abstraction Reactivity Patterns from A to Y: The Valence Bond Way. Angew. Chem 2012, 51, 5556. [DOI] [PubMed] [Google Scholar]
- 13.Saouma CT; Mayer JM Do spin state and spin density affect hydrogen atom transfer reactivity? Chem. Sci 2014, 5, 21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Mandal D; Shaik S Interplay of Tunneling, Two-State Reactivity, and Bell-Evans-Polanyi Effects in C-H Activation by Nonheme Fe(IV)O Oxidants. J. Am. Chem. Soc 2016, 138, 2094. [DOI] [PubMed] [Google Scholar]
- 15.Klein J; Mandal D; Ching WM; Mallick D; Que L Jr.; Shaik S Privileged Role of Thiolate as the Axial Ligand in Hydrogen Atom Transfer Reactions by Oxoiron(IV) Complexes in Shaping the Potential Energy Surface and Inducing Significant H-Atom Tunneling. J. Am. Chem. Soc 2017, 139, 18705. [DOI] [PubMed] [Google Scholar]
- 16.Baglia RA; Prokop-Prigge KA; Neu HM; Siegler MA; Goldberg DP Mn(V)(O) versus Cr(V)(O) Porphyrinoid Complexes: Structural Characterization and Implications for Basicity Controlling H-Atom Abstraction. J. Am. Chem. Soc 2015, 137, 10874. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Kang Y; Chen H; Jeong YJ; Lai W; Bae EH; Shaik S; Nam W Enhanced reactivities of iron(IV)-oxo porphyrin pication radicals in oxygenation reactions by electron-donating axial ligands. Chemistry 2009, 15, 10039. [DOI] [PubMed] [Google Scholar]
- 18.Usharani D; Lacy DC; Borovik AS; Shaik S Dichotomous hydrogen atom transfer vs proton-coupled electron transfer during activation of X-H bonds (X = C, N, O) by nonheme iron-oxo complexes of variable basicity. J. Am. Chem. Soc 2013, 135, 17090. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Parsell TH; Yang MY; Borovik AS C-H Bond Cleavage with Reductants: Re-Investigating the Reactivity of Monomeric Mn-III/IV-Oxo Complexes and the Role of Oxo Ligand Basicity. J. Am. Chem. Soc 2009, 131, 2762. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Gardner KA; Kuehnert LL; Mayer JM Hydrogen Atom Abstraction by Permanganate: Oxidations of Arylalkanes in Organic Solvents. Inorg. Chem 1997, 36, 2069. [DOI] [PubMed] [Google Scholar]
- 21.Mayer JM Hydrogen Atom Abstraction by Metal−Oxo Complexes: Understanding the Analogy with Organic Radical Reactions. Acc. Chem. Res 1998, 31, 441. [Google Scholar]
- 22.Warren JJ; Tronic TA; Mayer JM Thermochemistry of Proton-Coupled Electron Transfer Reagents and its Implications. Chem. Rev 2010, 110, 6961. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Guengerich FP; Kim DH Enzymic oxidation of ethyl carbamate to vinyl carbamate and its role as an intermediate in the formation of 1,N6-ethenoadenosine. Chem. Res. Toxicol 1991, 4, 413. [DOI] [PubMed] [Google Scholar]
- 24.Oritz de Montellano PR Cytochrome-P-450 Catalysis - Radical Intermediates and Dehydrogenation Reactions. Trends. Pharmacol. Sci 1989, 10, 354. [DOI] [PubMed] [Google Scholar]
- 25.Guan XM; Fisher MB; Lang DH; Zheng YM; Koop DR; Rettie AE Cytochrome P450-dependent desaturation of lauric acid: isoform selectivity and mechanism of formation of 11-dodecanoic acid. Chem. Biol. Interact 1998, 110, 103. [DOI] [PubMed] [Google Scholar]
- 26.Newcomb M; Chandrasena REP; Lansakara-P DSP; Kim HY; Lippard SJ; Beauvais LG; Murray LJ; Izzo V; Hollenberg PF; Coon MJ Desaturase reactions complicate the use of norcarane as a mechanistic probe. Unraveling the mixture of twenty-plus products formed in enzyme-catalyzed oxidations of norcarane. J. Org. Chem 2007, 72, 1121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Ortiz de Montellano PR; Nelson SD Rearrangement Reactions Catalyzed by Cytochrome P450s. Arch. Biochem. Biophys 2011, 507, 95. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Grant JL; Mitchell ME; Makris TM Catalytic strategy for carbon-carbon bond scission by the cytochrome P450 OleT. Proc. Natl. Acad. Sci. U.S.A 2016, 113, 10049. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Hsieh CH; Huang X; Amaya JA; Rutland CD; Keys CL; Groves JT; Austin RN; Makris TM The Enigmatic P450 Decarboxylase OleT Is Capable of, but Evolved To Frustrate, Oxygen Rebound Chemistry. Biochemistry 2017, 56, 3347. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Hayashi Y; Yamazaki I The oxidation-reduction potentials of compound I/compound II and compound II/ferric couples of horseradish peroxidases A2 and C. J. Biol. Chem 1979, 254, 9101. [PubMed] [Google Scholar]
- 31.Wang X; Peter S; Ullrich R; Hofrichter M; Groves JT Driving Force for Oxygen-Atom Transfer by Heme-Thiolate Enzymes. Angew. Chem 2013, 52, 9238. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.DiLabio GA; Pratt DA; LoFaro AD; Wright JS Theoretical Study of X−H Bond Energetics (X = C, N, O, S): Application to Substituent Effects, Gas Phase Acidities, and Redox Potentials. J. Phys. Chem. A 1999, 103, 1653. [Google Scholar]
- 33.Zhao B; Guengerich FP; Voehler M; Waterman MR Role of active site water molecules and substrate hydroxyl groups in oxygen activation by cytochrome P450 158A2 - A new mechanism of proton transfer. J. Biol. Chem 2005, 280, 42188. [DOI] [PubMed] [Google Scholar]
- 34.Zhao B; Guengerich FP; Bellamine A; Lamb DC; Izumikawa M; Lei L; Podust LM; Sundaramoorthy M; Kalaitzis JA; Reddy LM; Kelly SL; Moore BS; Stec D; Voehler M; Falck JR; Shimada T; Waterman MR Binding of two flaviolin substrate molecules, oxidative coupling, and crystal structure of Streptomyces coelicolor A3(2) cytochrome P450 158A2. J. Biol. Chem 2005, 280, 11599. [DOI] [PubMed] [Google Scholar]
- 35.Zhao Y; Hernandez-Pagan EA; Vargas-Barbosa NM; Dysart JL; Mallouk TE A High Yield Synthesis of Ligand-Free Iridium Oxide Nanoparticles with High Electrocatalytic Activity. J. Phys. Chem. Lett 2011, 2, 402. [Google Scholar]
- 36.Farhangrazi ZS; Copeland BR; Nakayama T; Amachi T; Yamazaki I; Powers LS Oxidation-Reduction Properties of Compounds I and II of Arthromyces ramosus Peroxidase. Biochemistry 1994, 33, 5647. [DOI] [PubMed] [Google Scholar]
- 37.He B; Sinclair R; Copeland BR; Makino R; Powers LS; Yamazaki I The structure-function relationship and reduction potentials of high oxidation states of myoglobin and peroxidase. Biochemistry 1996, 35, 2413. [DOI] [PubMed] [Google Scholar]
- 38.George P; Irvine DH The reaction of metmyoglobin with strong oxidizing agents. Biochem. J 1954, 58, 188. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Assuming the oxidant and its H-atom reduced form (e.g. P450-I and P450-II, respectively) have the same entropy of solvation ( Ssolv0) the O-H BDFE can be obtained by adding 1.8 kcal/mol to the calculated BDE.22.
- 40.Nagata K; Liberato DJ; Gillette JR; Sasame HA An unusual metabolite of testosterone. 17 beta-Hydroxy-4,6-androstadiene-3-one. Drug. Metab. Dispos 1986, 14, 559. [PubMed] [Google Scholar]
- 41.Wang X; Peter S; Kinne M; Hofrichter M; Groves JT Detection and Kinetic Characterization of a Highly Reactive Heme–Thiolate Peroxygenase Compound I. J. Am. Chem. Soc 2012, 134, 12897. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Yosca TH; Ledray AP; Ngo J; Green MT A new look at the role of thiolate ligation in cytochrome P450. J. Biol. Inorg. Chem 2017, 22, 209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Green MT; Dawson JH; Gray HB Oxoiron(IV) in Chloroperoxidase Compound II Is Basic: Implications for P450 Chemistry. Science 2004, 304, 1653. [DOI] [PubMed] [Google Scholar]
- 44.Gupta R; Borovik AS Monomeric Mn-III/II and Fe-III/II complexes with terminal hydroxo and oxo ligands: Probing reactivity via O-H bond dissociation energies. J. Am. Chem. Soc 2003, 125, 13234. [DOI] [PubMed] [Google Scholar]
- 45.Yin GC; Danby AM; Kitko D; Carter JD; Scheper WM; Busch DH Understanding the selectivity of a moderate oxidation catalyst: Hydrogen abstraction by a fully characterized, activated catalyst, the robust dihydroxo manganese(IV) complex of a bridged cyclam. J. Am. Chem. Soc 2007, 129, 1512. [DOI] [PubMed] [Google Scholar]
- 46.Yin GC; Danby AM; Kitko D; Carter JD; Scheper WM; Busch DH Oxidative Reactivity Difference among the Metal Oxo and Metal Hydroxo Moieties: pH Dependent Hydrogen Abstraction by a Manganese(IV) Complex Having Two Hydroxide Ligands. J. Am. Chem. Soc 2008, 130, 16245. [DOI] [PubMed] [Google Scholar]
- 47.Feng Y; Gunnoe TB; Grimes TV; Cundari TR Octahedral [TpRu(PMe3)(2)OR](n+) complexes (Tp = hydridotris(pyrazolyl) borate; R = H or Ph; n=0 or 1): Reactions at Ru(II) and Ru(III) oxidation states with substrates that possess carbon-hydrogen bonds. Organometallics 2006, 25, 5456. [Google Scholar]
- 48.Zurek J; Foloppe N; Harvey JN; Mulholland AJ Mechanisms of reaction in cytochrome P450: Hydroxylation of camphor in P450cam. Org. Biomol. Chem 2006, 4, 3931. [DOI] [PubMed] [Google Scholar]
- 49.Shaik S; Kumar D; de Visser SP; Altun A; Thiel W Theoretical perspective on the structure and mechanism of cytochrome P450 enzymes. Chem. Rev 2005, 105, 2279. [DOI] [PubMed] [Google Scholar]
- 50.Shaik S; Cohen S; Wang Y; Chen H; Kumar D; Thiel W P450 Enzymes: Their Structure, Reactivity, and Selectivity-Modeled by QM/MM Calculations. Chem. Rev 2010, 110, 949. [DOI] [PubMed] [Google Scholar]
- 51.Schoneboom JC; Cohen S; Lin H; Shaik S; Thiel W Quantum mechanical/molecular mechanical investigation of the mechanism of C-H hydroxylation of camphor by cytochrome P450(cam): Theory supports a two-state rebound mechanism. J. Am. Chem. Soc 2004, 126, 4017. [DOI] [PubMed] [Google Scholar]
- 52.Lonsdale R; Harvey JN; Mulholland AJ Inclusion of Dispersion Effects Significantly Improves Accuracy of Calculated Reaction Barriers for Cytochrome P450 Catalyzed Reactions. J. Phys. Chem. Lett 2010, 1, 3232. [Google Scholar]
- 53.Lonsdale R; Harvey JN; Mulholland AJ Effects of Dispersion in Density Functional Based Quantum Mechanical/Molecular Mechanical Calculations on Cytochrome P450 Catalyzed Reactions. J. Chem. Theory. Comput 2012, 8, 4637. [DOI] [PubMed] [Google Scholar]
- 54.Mandal D; Mallick D; Shaik S Kinetic Isotope Effect Determination Probes the Spin of the Transition State, Its Stereochemistry, and Its Ligand Sphere in Hydrogen Abstraction Reactions of Oxoiron(IV) Complexes. Acc. Chem. Res 2018, 51, 107. [DOI] [PubMed] [Google Scholar]
- 55.Mandal D; Ramanan R; Usharani D; Janardanan D; Wang B; Shaik S How does tunneling contribute to counterintuitive H-abstraction reactivity of nonheme Fe(IV)O oxidants with alkanes? J. Am. Chem. Soc 2015, 137, 722. [DOI] [PubMed] [Google Scholar]
- 56.Bim D; Maldonado-Dominguez M; Rulisek L; Srnec M Beyond the classical thermodynamic contributions to hydrogen atom abstraction reactivity. Proc. Natl. Acad. Sci. U.S.A 2018, 115, E10287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Jiang YY; He X; de Montellano PRO Radical intermediates in the catalytic oxidation of hydrocarbons by bacterial and human cytochrome P450 enzymes. Biochemistry 2006, 45, 533. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Frisch MJ; Trucks GW; Schlegel HB; Scuseria GE; Robb MA; Cheeseman JR; Scalmani G; Barone V, M. B; Petersson GA; Nakatsuji H; Caricato M; Li X, H. HP; Izmaylov AF; Bloino J, Z. G; Sonnenberg JL; Hada M; Ehara M; Toyota K; Fukuda R; Hasegawa J; Ishida M; Nakajima T; Honda Y; Kitao O; Nakai H; Vreven T; Montgomery JA Jr.; P. JE; Ogliaro F; Bearpark M; Heyd JJ; Brothers E; Kudin KN; Staroverov VN; Kobayashi R, N. J, Raghavachari K, Rendell A, Burant JC, Iyengar SS, Tomasi J, Cossi M, Rega N, Millam JM, Klene M, Knox JE, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Martin RL, Morokuma K, Zakrzewski VG, Voth GA, Salvador P, Dannenberg JJ, Dapprich S,; Daniels AD; Farkas Ö, F. JB, Ortiz JV, Cioslowski J, and Fox DJ; Gaussian 09, Revision C.01 Gaussian Inc., Wallingford, CT, 2009: Wallingford CT. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
